Ticker Details
Lineage Cell Therapeutics, Inc.
IPO Date:	April 1, 1992
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$371.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.05 | 3.72%
Avg Daily Range (30 D):	$0.05 | 2.87%
Avg Daily Range (90 D):	$0.05 | 2.85%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	1.08M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	296
Avg Trade Size (Sh.) (30 D):	199
Avg Trade Size (Sh.) (90 D):	211

Institutional Trades
Total Institutional Trades:	50
Avg Institutional Trade:	$3.75M
Avg Institutional Trade (30 D):	$.51M
Avg Institutional Trade (90 D):	$1.07M
Avg Institutional Trade Volume:	2.78M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.27M
Avg Closing Trade (30 D):	$.51M
Avg Closing Trade (90 D):	$1.58M
Avg Closing Volume:	4.13M

News

Apr 10, 2026 @ 1:55 PM Biotechs Racing to Translate Longevity Science Int... Source: Usa News Group

Mar 18, 2026 @ 2:00 PM A Key "Master" Protein That Declines by Half After... Source: Equity-Insider.Com

Jan 29, 2026 @ 6:31 PM Longevity Biotech Stocks Surge as $27 Trillion Hea... Source: Prnewswire

Jul 30, 2025 @ 9:07 PM W.P. Carey (WPC) Q2 AFFO Jumps 9.4% Source: Jesterai

Feb 11, 2025 @ 9:45 AM Refrigerated Warehousing Market Revenues to Grow f... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.28	$	$-.28
Diluted EPS	$-.28	$	$-.28
Revenue	$14.56M	$6.61M	$14.56M
Gross Profit
Net Income / Loss	$-63.37M	$.89M	$-63.37M
Operating Income / Loss	$-36.62M	$-6.55M	$-36.62M
Cost of Revenue
Net Cash Flow	$-5.03M	$.35M	$-5.03M
PE Ratio